These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 24652550)

  • 1. Predictive impact of the decreasing rate of intrathoracic impedance in worsening chronic heart failure.
    Yamada S; Suzuki H; Kamiyama Y; Saitoh S; Takeishi Y
    J Interv Card Electrophysiol; 2014 Jun; 40(1):87-91. PubMed ID: 24652550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracardiac impedance after cardiac resynchronization therapy is a novel predictor for worsening of heart failure.
    Suzuki H; Nodera M; Kamioka M; Kaneshiro T; Kamiyama Y; Takeishi Y
    Heart Vessels; 2017 Aug; 32(8):926-931. PubMed ID: 28181011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved algorithm to detect fluid accumulation via intrathoracic impedance monitoring in heart failure patients with implantable devices.
    Sarkar S; Hettrick DA; Koehler J; Rogers T; Grinberg Y; Yu CM; Abraham WT; Small R; Tang WH
    J Card Fail; 2011 Jul; 17(7):569-76. PubMed ID: 21703529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significant increase in the incidence of ventricular arrhythmic events after an intrathoracic impedance change measured with a cardiac resynchronization therapy defibrillator.
    Sekiguchi Y; Tada H; Yoshida K; Seo Y; Li S; Tejima T; Shoda M; Kamakura S; Aonuma K
    Circ J; 2011; 75(11):2614-20. PubMed ID: 21891969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of fluid assessment based on intrathoracic impedance monitoring in patients with systolic heart failure.
    Soga Y; Ando K; Arita T; Hyodo M; Goya M; Iwabuchi M; Nobuyoshi M
    Circ J; 2011; 75(1):129-34. PubMed ID: 21127381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrathoracic impedance vs daily weight monitoring for predicting worsening heart failure events: results of the Fluid Accumulation Status Trial (FAST).
    Abraham WT; Compton S; Haas G; Foreman B; Canby RC; Fishel R; McRae S; Toledo GB; Sarkar S; Hettrick DA;
    Congest Heart Fail; 2011; 17(2):51-5. PubMed ID: 21449992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathoracic impedance changes reflect reverse left ventricular remodeling in response to cardiac resynchronization therapy in chronic heart failure patients.
    Kaneshiro T; Suzuki H; Yamada S; Kamiyama Y; Saitoh S; Takeishi Y
    Int Heart J; 2012; 53(4):249-52. PubMed ID: 22878804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical utility of intrathoracic impedance monitoring to alert patients with an implanted device of deteriorating chronic heart failure.
    Vollmann D; Nägele H; Schauerte P; Wiegand U; Butter C; Zanotto G; Quesada A; Guthmann A; Hill MR; Lamp B;
    Eur Heart J; 2007 Aug; 28(15):1835-40. PubMed ID: 17309902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The lung impedance monitoring in treatment of chronic heart failure (the LIMIT-CHF study).
    Domenichini G; Rahneva T; Diab IG; Dhillon OS; Campbell NG; Finlay MC; Baker V; Hunter RJ; Earley MJ; Schilling RJ
    Europace; 2016 Mar; 18(3):428-35. PubMed ID: 26683599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in intrathoracic impedance are associated with subsequent risk of hospitalizations for acute decompensated heart failure: clinical utility of implanted device monitoring without a patient alert.
    Small RS; Wickemeyer W; Germany R; Hoppe B; Andrulli J; Brady PA; Labeau M; Koehler J; Sarkar S; Hettrick DA; Tang WH
    J Card Fail; 2009 Aug; 15(6):475-81. PubMed ID: 19643357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of different device-based intrathoracic impedance vectors for detection of heart failure events (from the Detect Fluid Early from Intrathoracic Impedance Monitoring study).
    Heist EK; Herre JM; Binkley PF; Van Bakel AB; Porterfield JG; Porterfield LM; Qu F; Turkel M; Pavri BB;
    Am J Cardiol; 2014 Oct; 114(8):1249-56. PubMed ID: 25150135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refined heart failure detection algorithm for improved clinical reliability of OptiVol alerts in CRT-D recipients.
    Vamos M; Nyolczas N; Bari Z; Bogyi P; Muk B; Szabo B; Ancsin B; Kiss RG; Duray GZ
    Cardiol J; 2018; 25(2):236-244. PubMed ID: 28653309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Device monitoring of heart failure in cardiac resynchronization therapy device recipients: a single-center experience with a novel multivector impedance monitoring system.
    Forleo GB; Panattoni G; Schirripa V; Papavasileiou LP; Della Rocca DG; Politano A; Ticconi F; Biscione C; Sergi D; Di Molfetta A; Santini L; Capria A; Romeo F
    J Cardiovasc Med (Hagerstown); 2013 Oct; 14(10):726-32. PubMed ID: 23996011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrathoracic impedance and pulmonary wedge pressure for the detection of heart failure deterioration.
    Maines M; Catanzariti D; Cirrincione C; Valsecchi S; Comisso J; Vergara G
    Europace; 2010 May; 12(5):680-5. PubMed ID: 20047927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous monitoring of intrathoracic impedance and right ventricular pressures in patients with heart failure.
    Vanderheyden M; Houben R; Verstreken S; Ståhlberg M; Reiters P; Kessels R; Braunschweig F
    Circ Heart Fail; 2010 May; 3(3):370-7. PubMed ID: 20197559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring of Daily Body Weight and Intrathoracic Impedance in Heart Failure Patients With a High Risk of Volume Overload Decompensation.
    Gudmundsson K; Lyngå P; Rosenqvist M; Braunschweig F
    Clin Cardiol; 2016 Aug; 39(8):446-52. PubMed ID: 27175605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathoracic impedance monitoring to predict decompensated heart failure.
    Ypenburg C; Bax JJ; van der Wall EE; Schalij MJ; van Erven L
    Am J Cardiol; 2007 Feb; 99(4):554-7. PubMed ID: 17293202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Change in intrathoracic impedance measures during acute decompensated heart failure admission: results from the Diagnostic Data for Discharge in Heart Failure Patients (3D-HF) Pilot Study.
    Whellan DJ; Droogan CJ; Fitzpatrick J; Adams S; McCarey MM; Andrel J; Mather P; Rubin S; Bonita R; Keith S
    J Card Fail; 2012 Feb; 18(2):107-12. PubMed ID: 22300777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implantable CRT device diagnostics identify patients with increased risk for heart failure hospitalization.
    Perego GB; Landolina M; Vergara G; Lunati M; Zanotto G; Pappone A; Lonardi G; Speca G; Iacopino S; Varbaro A; Sarkar S; Hettrick DA; Denaro A;
    J Interv Card Electrophysiol; 2008 Dec; 23(3):235-42. PubMed ID: 18810621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity and positive predictive value of implantable intrathoracic impedance monitoring as a predictor of heart failure hospitalizations: the SENSE-HF trial.
    Conraads VM; Tavazzi L; Santini M; Oliva F; Gerritse B; Yu CM; Cowie MR
    Eur Heart J; 2011 Sep; 32(18):2266-73. PubMed ID: 21362703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.